# Observational Study of Golimumab Intravenous Infusion

> **NCT02390700** · — · TERMINATED · sponsor: **Janssen Inc.** · enrollment: 78 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Golimumab Intravenous

## Key facts

- **NCT ID:** NCT02390700
- **Lead sponsor:** Janssen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 78 (ACTUAL)
- **Why stopped:** Business decision based on lack of enrollment
- **Last updated:** 2016-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02390700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02390700, "Observational Study of Golimumab Intravenous Infusion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02390700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*